Inivata announces launch of clinical trial to evaluate impact of InVisionFirst®-Lung liquid biopsy test on time to appropriate treatment in advanced lung cancer
Horizon Discovery is a world-leader in the application of gene editing and gene modulation technologies and is at the centre of innovation and drug discovery.
Our senior team has worked together for many years, delivering high-level strategic healthcare consultancy with seamless execution and unrivalled market intelligence.
Consilium Healthcare - RT @alliancerm: A big thanks to @Synpromics for your contribution. So glad you were able to join us! https://t.co/D1VxfoprQ3